Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Recruiting

A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma

NCT06296121

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Chelyabinsk Regional Clinical Hospital Chelyabinsk, Russia
  • Kuzbass Regional Clinical Hospital named after S.V. Belyaev Kemerovo, Russia
  • Regional Clinical Hospital Krasnoyarsk, Russia
  • Moscow City Clinical Hospital 52 Moscow, Russia
View all 14 locations
View Trial Details
Recruiting

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

NCT03110822

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Global Oncology, Inc. Alhambra, California, United States
  • Comprehensive Blood and Cancer Center Bakersfield, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States
  • Compassionate Care Research Group, Inc. Fountain Valley, California, United States
View all 13 locations
View Trial Details

Related conditions